Skip to content

Nuvation Bio

US · NUVB #2898 by market cap Listed 1970
3.80 -0.01 -0.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Citi Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12
    Market Newswire · 2026/10/16
  • Rating change
    Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating
    Market Newswire · 2026/9/15
  • Rating change
    Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13
    Market Newswire · 2026/8/7
  • Rating change
    B. Riley Securities Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $14
    Market Newswire · 2026/8/7
  • Rating change
    RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $19
    Market Newswire · 2026/7/7
  • Rating change
    RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $19
    Market Newswire · 2026/7/21
  • Rating change
    Cantor Fitzgerald Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12
    Market Newswire · 2026/8/21
  • Rating change
    H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $21
    Market Newswire · 2026/7/27
  • Rating change
    Citi Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12
    Market Newswire · 2026/9/30
  • Rating change
    Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $11
    Market Newswire · 2026/9/15
  • RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/11/5
  • Rating change
    RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $20
    Market Newswire · 2026/10/14
  • J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $11
    Market Newswire · 2026/11/9
  • Rating change
    A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $21
    Market Newswire · 2026/8/7
  • JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12
    Market Newswire · 2026/11/5
  • Rating change
    J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    J.P. Morgan Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13
    Market Newswire · 2026/8/18
  • H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21
    Market Newswire · 2026/11/5
  • Rating change
    Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)
    TipRanks · 2026/9/15
  • A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $11 to $21
    Market Newswire · 2026/11/6
  • Rating change
    H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)
    TipRanks · 2026/5/27
  • Rating change
    JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12
    Market Newswire · 2026/7/22
  • Rating change
    H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21
    Market Newswire · 2026/7/28
  • Rating change
    H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/5/27
  • Rating change
    TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating
    Market Newswire · 2026/6/2

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Nuvation Bio discussion 0 comments

Add a comment